miR-155 inhibitor ameliorated LPS-induced mouse AKI through the reduction in inflammatory cells by regulating the target Suppressor Of Cytokine Signaling 1 (SOCS1) and Signal Transducer And Activator Of Transcription (STAT)1 mRNAs [119]. The gene discussed is SOCS1; the disease is acute kidney injury.